Net sales amounted to 34 (0) TSEK in the second quarter of 2022. In the same period, net profit/loss totalled -8 187 (-2 557) TSEK. Cash flow from operating activities was -4 259 (-1 716) TSEK in the period from April 1[st] to June 30[th] 2022.

Net sales amounted to 5 829 (0) TSEK in the first half of 2022, while net profit/loss totalled -12 201 (-6 657) TSEK. Cash flow from operating activities was -10 361 (-5 519) TSEK in the period from January 1[st] to June 30[th] 2022.

Developments in the second quarter of 2022

TC TECH completed a fully subscribed rights issue of 6,349,349 shares in accordance with the resolution made at the Extraordinary General Meeting on April 7, 2022. Through the issue, the company's share capital has increased by SEK 507,947.92, while the company has been allocated approximately SEK 24.8 million in cash and cash equivalents.

TC TECH announced that the company has received its first order in the biotechnology sector from Israel-based diagnostics company Picodya Technologies Lt. Order is worth approximately SEK 6.5 million relating to production systems and peripherals for the manufacture of consumables in microfluidics/diagnostics.

Developments after June 30, 2022

TC TECH announced that the bid company CIMON Acquisition AB on July 5 announced a mandatory cash offer to shareholders in TC TECH Sweden AB (publ). And that CIMON Acquisition AB on July 27 published an offer document regarding a mandatory public offer to the shareholders of TC TECH Sweden AB (publ).